With the shelf now effective, Yorkville can begin selling shares immediately. Monitor daily volume and price action for signs of accelerated selling, particularly if the stock trades near or below the assumed $0.81 reference price. The toxic conversion terms (97% of lowest VWAP) create a structural overhang that will likely cap any upside rallies.
Price Chart
Executive Summary
The SEC declared effective Health In Tech's S-3 registration statement (File No. 333-298758) on October 15, 2026. This allows Yorkville to resell up to 34,224,247 shares of Class A common stock under the Standby Equity Purchase Agreement (SEPA), which includes up to $14.25M in convertible notes and a $20M equity line. The effectiveness removes the final regulatory barrier, enabling immediate dilution of up to ~35.5% of current shares outstanding.
Key Facts
- Effectiveness date: October 15, 2026 for S-3 registration statement 333-298758
- Up to 34,224,247 shares registered for resale by Yorkville (YA II PN, LTD)
- Includes up to 9,532,889 conversion shares from convertible notes and up to 24,691,358 advance shares under the SEPA
- Yorkville can sell at 97% of lowest VWAP, with notes carrying 8.75% interest, 5% discount, and 4% payment premium
- Full issuance would dilute existing holders by approximately 35.5%
Financial Impact
Potential dilution of ~35.5% of current shares outstanding; Yorkville can sell at 97% of lowest VWAP, creating persistent downward price pressure
Risk Factors
- Immediate and ongoing dilution from Yorkville's ability to sell shares at a discount to market price
- Persistent downward price pressure from the 97% of lowest VWAP conversion mechanism
- Company's history of 15 offering/registration statements in 24 months signals persistent capital needs
- Potential for accelerated selling if the stock price declines, triggering further discount-driven selling
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003254 |
| Document: 9999999995-26-003254-index.html | 9999999995-26-003254 |
| Document: 9999999995-26-003254.txt | 9999999995-26-003254 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+60 | — | — |
Oct 22, 2026 3d ago | 3 | $0.5623 | awaiting T+60 | — | $0.5359 (−4.70%) |
Oct 16, 2026 10d ago | 8-K | $0.6350 | awaiting T+60 | — | $0.5359 (+15.61%) |
Oct 16, 2026 10d ago | EFFECT | $0.6520 | awaiting T+60 | — | $0.5359 (+17.81%) |
Oct 13, 2026 13d ago | DEF 14A | $0.6780 | awaiting T+60 | — | $0.5359 (+20.96%) |
Oct 9, 2026 16d ago | S-3/A | $0.7200 | awaiting T+60 | — | $0.5359 (+25.57%) |
Sep 30, 2026 26d ago | Press Release | $0.7380 | awaiting T+60 | — | $0.5359 (−27.38%) |
Sep 29, 2026 27d ago | SC 13G | $0.8525 | awaiting T+60 | — | $0.5359 (−37.14%) |
Sep 4, 2026 7w ago | S-3 | $0.9801 | awaiting T+60 | — | $0.5359 (+45.32%) |
Aug 13, 2026 10w ago | Press Release | $1.01 | awaiting T+60 | — | $0.5359 (+46.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers